State Street
BIVI icon

State Street’s BioVie BIVI Stock Holding History

State Street’s Portfolio BIVI Stock Details BIVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,602
Closed -$14.8K – 4294
2025
Q2 		$14.8K Hold
1,602
– – ﹤0.01% 4221
2025
Q1 		$15.7K Hold
1,602
– – ﹤0.01% 4229
2024
Q4 		$32K Buy
+1,602
New +$38.6K ﹤0.01% 4179
2024
Q3 		– Sell
-292
Closed -$11.7K – 4300
2024
Q2 		$11.7K Sell
292
-1,460
-83% -$69.9K ﹤0.01% 4316
2024
Q1 		$92.6K Sell
1,752
-5
-0.3% -$513 ﹤0.01% 4042
2023
Q4 		$221K Buy
1,757
+863
+97% +$259K ﹤0.01% 3877
2023
Q3 		$305K Buy
894
+70
+8% +$27.4K ﹤0.01% 3807
2023
Q2 		$355K Buy
824
+532
+182% +$358K ﹤0.01% 3801
2023
Q1 		$236K Buy
292
+90
+45% +$59.6K ﹤0.01% 4018
2022
Q4 		$157K Buy
202
+51
+34% +$27.6K ﹤0.01% 4207
2022
Q3 		$38K Hold
151
– – ﹤0.01% 4709
2022
Q2 		$22K Hold
151
– – ﹤0.01% 4862
2022
Q1 		$71K Buy
151
+3
+2% +$1.11K ﹤0.01% 4726
2021
Q4 		$67K Buy
+148
New +$85.5K ﹤0.01% 4650

Other funds holding BIVI

DC
Diametric Capital Boston, Massachusetts $385M AUM 31.69% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.31B AUM 62.01% 1-Year Est. Return
PWM
Prosperity Wealth Management San Ramon, California $300M AUM 28.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

State Street's BIVI Position: Q3 2025 in Review

State Street sold out of BioVie (BIVI) in Q3 2025, closing a stake of 1,602 shares — an estimated $14.8K sold.

State Street first reported a position in BIVI in Q4 2021 and held it in 14 quarters. The position peaked at $355K in Q2 2023. 32 funds tracked by Wall St. Rank hold BIVI as of Q3 2025.

  • State Street reported no remaining BioVie position as of Q3 2025 after selling out during the quarter.
  • State Street sold 1,602 BioVie shares in Q3 2025, an estimated $14.8K.
  • State Street first reported a position in BioVie in Q4 2021 and held it in 14 quarters.
  • State Street's BioVie position peaked at $355K in Q2 2023.
  • 32 funds tracked by Wall St. Rank held BioVie as of Q3 2025.

Based on State Street's 13F filing for Q3 2025, filed 14 Nov 2025.